Countries citing papers authored by Atsushi Shirahata
Since
Specialization
Citations
This map shows the geographic impact of Atsushi Shirahata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Shirahata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Shirahata more than expected).
Fields of papers citing papers by Atsushi Shirahata
This network shows the impact of papers produced by Atsushi Shirahata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Shirahata. The network helps show where Atsushi Shirahata may publish in the future.
Co-authorship network of co-authors of Atsushi Shirahata
This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Shirahata.
A scholar is included among the top collaborators of Atsushi Shirahata based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Atsushi Shirahata. Atsushi Shirahata is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Shirahata, Atsushi & Kenji Hibi. (2014). Serum vimentin methylation as a potential marker for colorectal cancer.. PubMed. 34(8). 4121–5.35 indexed citations
3.
Hibi, Kenji, Tetsuhiro Goto, Atsushi Shirahata, et al.. (2012). Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.. PubMed. 32(3). 787–90.8 indexed citations
4.
Shirahata, Atsushi, et al.. (2012). [Significance of Onodera's prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy].. PubMed. 39(2). 231–5.10 indexed citations
5.
Shirahata, Atsushi, Kazuma Sakuraba, Yohei Kitamura, et al.. (2012). Detection of vimentin methylation in the serum of patients with gastric cancer.. PubMed. 32(3). 791–4.13 indexed citations
Shirahata, Atsushi, Fan Wu, Kazuma Sakuraba, et al.. (2011). MACC 1 as a marker for vascular invasive hepatocellular carcinoma.. PubMed. 31(3). 777–80.63 indexed citations
Shirahata, Atsushi, Kazuma Sakuraba, Tetsuhiro Goto, et al.. (2010). Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients.. PubMed. 30(12). 5015–8.21 indexed citations
Hibi, Kenji, Makiko Sakata, Kazuma Sakuraba, et al.. (2009). CD133 gene overexpression is frequently observed in early colorectal carcinoma.. PubMed. 56(93). 995–7.3 indexed citations
16.
Sakuraba, Kazuma, Takashi Yasuda, Makiko Sakata, et al.. (2009). Down-regulation of Tip60 gene as a potential marker for the malignancy of colorectal cancer.. PubMed. 29(10). 3953–5.42 indexed citations
17.
Kitamura, Yohei, Atsushi Shirahata, Makiko Sakata, et al.. (2009). Frequent methylation of Vimentin in well-differentiated gastric carcinoma.. PubMed. 29(6). 2227–9.19 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.